In October 2025, researchers from the MRC Translational Immune Discovery Unit led activities on researching gut bacteria at Oxford Science + Ideas Festival.
A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.
New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn\u2019s disease - paving the way for targeted treatments.
RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.
The study, led by researchers at the MRC Translational Immune Discovery Unit and the CAMS Oxford Institute (NDM), found that dominant T cell responses found in many individuals 4 years after infection are associated with mild COVID-19 disease, and likely play important protective roles in subsequent viral infection events.
Iron deficiency is the world\u2019s most common nutritional deficiency, affecting an estimated two billion people worldwide. The Drakesmith Group is collaborating with researchers across the University and internationally to tackle this problem from multiple angles.
Hashem Koohy, Associate Professor of Systems Immunology, has been awarded funding from Wellcome to develop computational strategies to decipher the underlying rules of adaptive T cell immunity.
Oxford scientists build a connected, \u2018multi-organoid\u2019 platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
![\"\"](\"https://www.imm.ox.ac.uk/news/holly-russell-lee-placito-fellowship/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n